Clinical Trials Directory

Trials / Completed

CompletedNCT05508243

Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization of Hyaluronic Nasal Spray

Dermatologist-supervised Assessment of Primary and Accumulated Irritation Potential and Skin Sensitization Potential for the NASAL SPRAY Product

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Herbarium Laboratorio Botanico Ltda · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Evaluate the potential of Primary Dermal Irritability, Accumulated Dermal Irritability and Dermal Sensitization, of health products through the application of Patch Test, proving the safety of the product for topical use. The study will be conducted with a Brazilian sample in which 65 research participants will be included. Depending on the results, the present study may support the claim: dermatologically tested.

Conditions

Interventions

TypeNameDescription
OTHERHyaluronic Nasal SprayHealth care product - nasal application

Timeline

Start date
2022-10-17
Primary completion
2022-11-24
Completion
2022-11-24
First posted
2022-08-19
Last updated
2023-03-17

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT05508243. Inclusion in this directory is not an endorsement.

Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization of Hyaluronic Nasal Spray (NCT05508243) · Clinical Trials Directory